Melatonin long-term use heart failure risk
Analysis based on 6 articles · First reported Aug 29, 2026 · Last updated Sep 09, 2026
The study may raise concerns about the safety of long-term melatonin use, potentially affecting consumer behavior and sales of melatonin supplements. However, since the findings are preliminary and not causal, the impact on supplement manufacturers is likely limited in the short term.
A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that adults with chronic insomnia who used melatonin for at least 12 months had about a 90% higher risk of developing heart failure over five years compared to non-users. The study, based on data from the TriNetX Global Research Network, analyzed over 130,000 adults with insomnia. Heart failure occurred in 4.6% of melatonin users versus 2.7% of non-users. Melatonin users were also nearly 3.5 times more likely to be hospitalized for heart failure and had higher all-cause mortality (7.8% vs 4.3%). The findings are observational and do not prove causation. Researchers noted limitations including potential misclassification of over-the-counter users and unmeasured factors like insomnia severity. A separate NHANES analysis did not find a significant link, and a review of clinical trials showed mixed effects. Experts urge caution against long-term use without medical indication.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard